Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Natural Killer–Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy
Erin E Peterson, Kevin C. Barry
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Context-dependent functions of pattern recognition receptors in cancer
Si Ming Man, Brendan J. Jenkins
Nature reviews. Cancer (2022) Vol. 22, Iss. 7, pp. 397-413
Closed Access | Times Cited: 80
Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4
Ana Santiso, Ákos Heinemann, Julia Kargl
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 388-413
Open Access | Times Cited: 15
High hypoxia status in pancreatic cancer is associated with multiple hallmarks of an immunosuppressive tumor microenvironment
Hassan Sadozai, Animesh Acharjee, Hateem Zafar Kayani, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
From Pioneering Discoveries to Innovative Therapies: A Journey Through the History and Advancements of Nanoparticles in Breast Cancer Treatment
Fatemah Basingab, Omniah A. Alshahrani, Ibtehal AlAnsari, et al.
Breast Cancer Targets and Therapy (2025) Vol. Volume 17, pp. 27-51
Open Access
Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocarcinoma
Ioana Plesca, Iva Benešová, Carolin Beer, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1216-1216
Open Access | Times Cited: 23
Natural killer cell engagers: From bi‐specific to tri‐specific and tetra‐specific engagers for enhanced cancer immunotherapy
An Zhu, Yu Bai, Yanyang Nan, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 11
Open Access | Times Cited: 4
The Adverse Impact of Tumor Microenvironment on NK-Cell
Ziming Hu, Xiuxiu Xu, Haiming Wei
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 29
Dendritic-Cell-Vaccine-Based Immunotherapy for Hepatocellular Carcinoma: Clinical Trials and Recent Preclinical Studies
Long‐Bin Jeng, Li‐Ying Liao, Fu‐Ying Shih, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4380-4380
Open Access | Times Cited: 21
Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment
Athanasios Papadas, Gauri Deb, Alexander Cicala, et al.
Cell Reports (2022) Vol. 40, Iss. 7, pp. 111201-111201
Open Access | Times Cited: 19
IFNα and 5-Aza-2’-deoxycytidine combined with a dendritic-cell targeting DNA vaccine alter tumor immune cell infiltration in the B16F10 melanoma model
James T. Gordy, Avinaash K. Sandhu, Kaitlyn Fessler, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 11
Allogeneic NK cells induce the in vitro activation of monocyte-derived and conventional type-2 dendritic cells and trigger an inflammatory response under cancer-associated conditions
Elisa C. Toffoli, A.A. van Vliet, C.D. Forbes, et al.
Clinical & Experimental Immunology (2024) Vol. 216, Iss. 2, pp. 159-171
Open Access | Times Cited: 3
Deciphering age-specific molecular features in cervical cancer and constructing an angio-immune prognostic model
Xin Zhao, Xichen Fan, Lin Xiu, et al.
Medicine (2024) Vol. 103, Iss. 15, pp. e37717-e37717
Open Access | Times Cited: 3
Adoptive NK cell therapy: a potential revolutionary approach in longevity therapeutics
Xuewen Deng, Hiroshi Terunuma
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?
Qingyi Wang, Bin Xie, Shuang Liu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 24
Innate immunity: Looking beyond T-cells in radiation and immunotherapy combinations
Ryan McMahon, Criselle D’Souza, Paul J. Neeson, et al.
Neoplasia (2023) Vol. 46, pp. 100940-100940
Open Access | Times Cited: 9
Inside the Biology of the β3-Adrenoceptor
Amada Pasha, Annalisa Tondo, Claudio Favre, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 159-159
Open Access | Times Cited: 2
MICB Genetic Variants and Its Protein Soluble Level Are Associated with the Risk of Chronic GvHD and CMV Infection after Allogeneic HSCT
Jagoda Siemaszko, Marta Dratwa, Agnieszka Szeremet, et al.
Archivum Immunologiae et Therapiae Experimentalis (2024) Vol. 72, Iss. 1
Closed Access | Times Cited: 2
The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor Immunity
Thu Nguyen, R Müller, Daria Briukhovetska, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2608-2608
Open Access | Times Cited: 2
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma
María Monteagudo, Bruna Calsina, Milton E. Salazar-Hidalgo, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2024) Vol. 38, Iss. 6, pp. 101931-101931
Open Access | Times Cited: 2
NK/DC crosstalk-modulating antitumor activity via Sema3E/PlexinD1 axis for enhanced cancer immunotherapy
Awais Ali, Abdulaziz Alamri, Azraida Hajar
Immunologic Research (2024)
Closed Access | Times Cited: 2
Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapy
Simone Ielpo, Francesca Barberini, Farnaz Dabbagh Moghaddam, et al.
Cancer Treatment Reviews (2024) Vol. 131, pp. 102843-102843
Open Access | Times Cited: 2
NK Cell Anti-Tumor Surveillance in a Myeloid Cell-Shaped Environment
Eleonora Russo, Mattia Laffranchi, Luana Tomaipitinca, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 19
Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination
Weiqiang You, Jian Ouyang, Zerong Cai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Advances in research of biological functions of Isthmin-1
Menghuan Li, Yang Yang, Ma Qianhe, et al.
Journal of Cell Communication and Signaling (2023) Vol. 17, Iss. 3, pp. 507-521
Open Access | Times Cited: 7
Combining bulk and single-cell RNA-sequencing data to develop an NK cell-related prognostic signature for hepatocellular carcinoma based on an integrated machine learning framework
Qian Feng, Zhihao Huang, Lei Song, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top